These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9114912

  • 41. Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity.
    Wallin JD, Frishman WH.
    J Clin Pharmacol; 1989 Dec; 29(12):1057-68. PubMed ID: 2693499
    [Abstract] [Full Text] [Related]

  • 42. Dilevalol compared with propranolol and placebo for systemic hypertension.
    Schoenberger JA, Frishman WH, Wallin JD, Gorwit J, Davidov ME, Michelson EL, Bedsole GD, Cubbon J, Poland MP.
    Am J Cardiol; 1989 Jun 05; 63(19):45I-49I. PubMed ID: 2658529
    [Abstract] [Full Text] [Related]

  • 43. Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations.
    Given BD, Perentesis G, Christopher JD, Herron J, Patrick JE, Kramer WG, Affrime MB.
    Am J Cardiol; 1989 Jun 05; 63(19):12I-16I. PubMed ID: 2729123
    [Abstract] [Full Text] [Related]

  • 44. Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril.
    Fogari R, Poletti L, Tettamanti F, Cesana B, Savonitto S.
    G Ital Cardiol; 1990 Apr 05; 20(4):309-15. PubMed ID: 2197158
    [Abstract] [Full Text] [Related]

  • 45. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ, Smith L, Glover DR.
    J Hum Hypertens; 1990 Jun 05; 4 Suppl 2():85-90. PubMed ID: 2196372
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
    Abdelmawla AH, Langley RW, Szabadi E, Bradshaw CM.
    Br J Clin Pharmacol; 2001 Jun 05; 51(6):583-9. PubMed ID: 11422018
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.
    Grove A, McFarlane LC, Lipworth BJ.
    Thorax; 1995 Feb 05; 50(2):134-8. PubMed ID: 7701450
    [Abstract] [Full Text] [Related]

  • 50. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B, Cronin CJ, Graham BR, Prichard BN.
    J Cardiovasc Pharmacol; 1987 Feb 05; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [Abstract] [Full Text] [Related]

  • 51. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly.
    Clifton GG, Cook ME, Poland M, Wallin JD.
    J Clin Pharmacol; 1989 Jul 05; 29(7):603-8. PubMed ID: 2760254
    [Abstract] [Full Text] [Related]

  • 52. Blockade of the rate and force responses to phenylephrine on rat atria with labetalol.
    Simpson WW, McNeill JH.
    Res Commun Chem Pathol Pharmacol; 1980 Aug 05; 29(2):373-6. PubMed ID: 7414055
    [Abstract] [Full Text] [Related]

  • 53. A comparison of dilevalol and placebo in the management of isolated systolic hypertension using ambulatory monitoring.
    Silagy CA, McNeil JJ, Farish S, McGrath BP.
    Br J Clin Pharmacol; 1990 Nov 05; 30(5):657-64. PubMed ID: 2271366
    [Abstract] [Full Text] [Related]

  • 54. Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.
    Baba T, Murabayashi S, Aoyagi K, Ishizaki T.
    Eur J Clin Pharmacol; 1988 Nov 05; 35(1):9-15. PubMed ID: 2905992
    [Abstract] [Full Text] [Related]

  • 55. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
    Kennedy I, Levy GP.
    Br J Pharmacol; 1975 Apr 05; 53(4):585-92. PubMed ID: 238705
    [Abstract] [Full Text] [Related]

  • 56. Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors.
    Floreani M, Quintieri L, Varani K, Dorigo MT, Dorigo P.
    Eur J Pharmacol; 2008 Aug 20; 590(1-3):269-75. PubMed ID: 18571646
    [Abstract] [Full Text] [Related]

  • 57. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
    Cubeddu LX, Fuenmayor N, Varin F, Villagra VG, Colindres RE, Powell JR.
    J Cardiovasc Pharmacol; 1987 Aug 20; 10 Suppl 11():S81-4. PubMed ID: 2454374
    [Abstract] [Full Text] [Related]

  • 58. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
    Abdelmawla AH, Langley RW, Szabadi E, Bradshaw CM.
    Br J Clin Pharmacol; 1997 Jul 20; 44(1):61-8. PubMed ID: 9241098
    [Abstract] [Full Text] [Related]

  • 59. Investigation of the beta 2-agonist properties of dilevalol: metabolic effects of intravenous infusion.
    Kendall MJ, Lewis HM, Haffner CA, Hughes BA.
    J Hum Hypertens; 1990 Jun 20; 4 Suppl 2():65-8. PubMed ID: 2370646
    [Abstract] [Full Text] [Related]

  • 60. Beta-blocking agents with vasodilating action.
    Prichard BN.
    J Cardiovasc Pharmacol; 1992 Jun 20; 19 Suppl 1():S1-4. PubMed ID: 1378133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.